Rule 506(b); Investment Company Act Section 3(c)(1); Investment Company Act Section 3(c)(7)
First filed
2017-11-01
Latest filing
2017-11-01
First sale
2017-10-31
Filings
1 Form D
People
Named in Item 3 of its latest Form D, filed 2017-11-01
Related persons
Name
Relationship
Clarification
FHMLS IX, L.P.
RelationshipExecutive Officer
ClarificationGeneral Partner of the Issuer
FHMLS IX, L.L.C.
RelationshipExecutive Officer
ClarificationGeneral Partner of the General Partner of the Issuer
Patrick J. Heron
RelationshipExecutive Officer
ClarificationMember of the general partner of the Issuer's general partner
James N. Topper
RelationshipExecutive Officer
ClarificationMember of the general partner of the Issuer's general partner
Frazier Management, L.L.C.
RelationshipPromoter
ClarificationThe Issuer's affiliated advisor
Daniel J. Estes
RelationshipPromoter
Clarification—
History
2017-11-01Form D filed · 021-297918
The other funds of Frazier Healthcare Partners (25 on Form ADV) and every Form D as filedSee plans
The firm and the filings behind Frazier Life Sciences IX, L.P.
A fund's Form D states its target and what it has sold so far. The dashboard puts it beside the adviser's other funds from Form ADV, the startups linked to it, and every amendment as filed.
The adviser's Venture page: its Form ADV funds, assets and other Form D offerings
Where co-filings link it, the startups this fund backed
Every Form D and amendment as filed, with what each one stated
Everyone its filings name, linked to their other funds and companies
Part of the Venture plan — $140/mo at launch pricing ($350 list)